drugset / Trial / NCT01866917
Study of TAP and Laparoscopic and Robotic Gynecologic Procedures and Obese Women
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Study the effect of the Transversis Abdominis Plane (TAP) block on pain after surgery for obese women undergoing laparoscopic or robotic gynecologic procedures.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-04
- Completion
- 2016-04
Outcome
Missed primary endpoint
Stopped: “Pharmacy stopped dispensing study medication”
registry analysis (superiority test); Transversus Abdominis Plane (TAP) Group B vs Saline Group A; p = .574; Chi-squared NCT01866917 ↗
registry analysis (superiority test); Transversus Abdominis Plane (TAP) Group B vs Saline Group A; p = .825; Interquartile range (IQR) 3; Chi-squared NCT01866917 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 0.5 % | — |
| Subject | Ropivacaine | Other / unclassified | 20 ml | — |
Indications
No indication recorded.